Navigating Breast Cancer: Axon Guidance Molecules as Breast Cancer Tumor Suppressors and Oncogenes
出版年份 2011 全文链接
标题
Navigating Breast Cancer: Axon Guidance Molecules as Breast Cancer Tumor Suppressors and Oncogenes
作者
关键词
-
出版物
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
Volume 16, Issue 3, Pages 257-270
出版商
Springer Nature
发表日期
2011-08-04
DOI
10.1007/s10911-011-9225-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasma netrin-1 is a diagnostic biomarker of human cancers
- (2011) Ganesan Ramesh et al. BIOMARKERS
- SLIT/ROBO1 Signaling Suppresses Mammary Branching Morphogenesis by Limiting Basal Cell Number
- (2011) Hector Macias et al. DEVELOPMENTAL CELL
- Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism
- (2010) Nao Hiramoto-Yamaki et al. JOURNAL OF CELL BIOLOGY
- EphrinB reverse signaling in cell-cell adhesion
- (2010) Hyun-Shik Lee et al. Cell Adhesion & Migration
- Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer
- (2009) Tomoko Fujikane et al. BREAST CANCER RESEARCH AND TREATMENT
- Interfering with multimerization of netrin-1 receptors triggers tumor cell death
- (2009) F Mille et al. CELL DEATH AND DIFFERENTIATION
- The Cleavage of Semaphorin 3C Induced by ADAMTS1 Promotes Cell Migration
- (2009) Cary Esselens et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of Mammary Gland Branching Morphogenesis by EphA2 Receptor Tyrosine Kinase
- (2009) David Vaught et al. MOLECULAR BIOLOGY OF THE CELL
- EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells
- (2009) B P Fox et al. ONCOGENE
- Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration
- (2009) J. Yuasa-Kawada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cells
- (2008) Hongjie Pan et al. BREAST CANCER RESEARCH AND TREATMENT
- Semaphorin 3B Inhibits the Phosphatidylinositol 3-Kinase/Akt Pathway through Neuropilin-1 in Lung and Breast Cancer Cells
- (2008) E. Castro-Rivera et al. CANCER RESEARCH
- SLITs Suppress Tumor Growth In vivo by Silencing Sdf1/Cxcr4 within Breast Epithelium
- (2008) R. Marlow et al. CANCER RESEARCH
- Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers – Results of a large scale microarray analysis
- (2008) Achim Rody et al. EUROPEAN JOURNAL OF CANCER
- Netrin-4 regulates angiogenic responses and tumor cell growth
- (2008) Mariana Nacht et al. EXPERIMENTAL CELL RESEARCH
- Slit-2 Induces a Tumor-suppressive Effect by Regulating β-Catenin in Breast Cancer Cells
- (2008) Anil Prasad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling
- (2008) Dana M. Brantley-Sieders et al. JOURNAL OF CLINICAL INVESTIGATION
- The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment
- (2008) Charlotte Rolny et al. JOURNAL OF EXPERIMENTAL MEDICINE
- EphrinB1 controls cell–cell junctions through the Par polarity complex
- (2008) Hyun-Shik Lee et al. NATURE CELL BIOLOGY
- Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor
- (2008) J Wykosky et al. ONCOGENE
- Netrin-4 inhibits angiogenesis via binding to neogenin and recruitment of Unc5B
- (2008) E. Lejmi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer
- (2008) J. Fitamant et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now